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ABSTRACT: The hepatotoxic effect of aqueous leaves extract of Cassia italica on some liver function 
parameters was investigated in albino rats. Five groups of the rats were administered the following graded doses of 
the extract orally:  0, 300, 600, 1500 and 3000 mg/kg bw, for groups 1, 2, 3, 4 and 5 respectively, once daily for 28 
days. The serum ALAT, ASAT and ALP levels were found to increase significantly (p<0.05) in all the groups when 
compared to the control; whereas the serum Albumin levels decreased significantly (p<0.05) in all the groups when 
compared with the control. There was also a significant increase in Total Bilirubin level (p<0.05) in the groups 
administered with 3000 and 1500 mg/kg bw, but the reverse was the case in the groups administered with 600 and 
300 mg/kg bw of the extract, which showed significant decrease (p<0.05) when compared with the control. These 
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Medicinal plants and herbs contain substances known 
to modern and ancient civilizations for their healing 
properties. A number of plants have been used in 
traditional medicine for many years; some do seem to 
work, although there may not be sufficient scientific 
data to confirm their efficacy (Sofowara, 1982). The 
medicinal value of these plants lies in some chemical 
substances they contain, that produce definite 
physiological action on the human body. The most 
important of these bioactive constituents of plants are 
alkaloids, tannins, flavonoids and phenolic 
compounds (Elsayed et al., 1992).  
 
Herbal knowledge is gathered through trial and error 
over a period of time. Traditional herbalists detect 
effective substances by trying them out on themselves 
or on patients and therefore, toxicity and side effects 
may be encountered during treatment (Bandiera et al., 
1999). Traditional medicines include practices, such 
as herbal medicine, ayurvedic medicine, unani 
medicine, acupuncture, as well as other medical 
knowledge and practices (not orthodox) all over the 
globe. Inappropriate use of traditional medicines or 
practices can have negative or dangerous effects and 
so, further research is needed to ascertain the efficacy 
and safety of the medicinal plants used in traditional 
medicine system (WHO, 2003). 
 
Cassia italica, also known as Cassia obovata or Senna 
italica as well as ‘Filasko’ in Hausa language, is a 
perennial plant that grows abundantly in the southern 
part of the eastern desert and commonly used in most 
parts of Nigeria for the treatment of constipation, 
oedema and skin diseases. Phytochemical studies on 
aerial parts of Cassia species demonstrated the 
presence of β-sitosterol, stigmasterol, α–amyrin, 
anthraquinone, anthrone, and probably other 
constituents (Acharya and Chtterjee, 1975). This study 
therefore, evaluated the hepatotoxicity effect of the 
plant’s aqeous extract on rat liver. 
 
MATERIALS AND METHODS 
Experimental Animals: The study was carried out with 
adult albino rats, weighing 180 - 220g of both sexes. 
The animals were purchased from animal house of the 
Department of Biological Sciences of Usmanu 
Danfodiyo University, Sokoto. The animals were 
provided with standard diet (Vital Feed) and fresh 
clean water ad libitum. They were allowed to 
acclimatize to the experimental conditions in cages for 
one week prior to the commencement of the 
experiment.  
 
Collection of the Plant Sample: The mature leaves of 
Cassia italica were collected from the farmland area 
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within the main campus of Usmanu Danfodiyo 
University, Sokoto. The plant was identified by a 
taxonomist in the herbarium of Botany Unit, 
Biological Sciences Department, Usmanu Danfodiyo 
University, Sokoto. Where a voucher specimen was 
kept for record purposes.  
 
Preparation of Aqueous Leaves Extract: The leaves of 
the plant were shed dried at room temperature and then 
pulverized to coarse powder. 400g of the powdered 
sample were dissolved in about 4 litres of water and 
left for 24 hours at room temperature. The mixture was 
filtered using muslin cloth after 24 hours to obtain the 
filtrate. The filtrate was evaporated in a drying cabinet 
at 45oC to obtain a concentrated extract. The 
concentrated extract was reconstituted in distilled 
water to obtain a known concentration of the extract 
(Lorke, 1983). 
 
Acute Toxicity Studies (Determination of LD50): The 
acute toxicity test was carried out based on OECD 
guideline (OECD, 2001). Five rats were randomly 
selected and marked to permit individual 
identification. The animals were weighed prior to the 
administration of the extract. One animal serves as the 
control and the four others were administered 
3000mg/kg body weight of the extract, orally in a 
single dose using intubation canola. Each animal was 
observed at the interval of one hour for the first four 
hours after dosing for any symptom of toxicity and 
subsequently for next 48 hours. The number of 
survivors was noted after 48 hours. The result was 
recorded on the basis of mortality and expressed as 
LD50. The animals were reweighed to determine 
change in weight over the 48 hours period. 
  
Sub-chronic Toxicity Test: Repeated toxicity study 
was carried out according to OECD guideline (OECD, 
2001). The animals were divided into five groups of 
five rats each. Group 1 served as control, receiving 
only 1 ml of distilled water daily. Groups 2, 3, 4 and 5 
were respectively administered 300, 600, 1500, and 
3000 mg/kg body weight of the extract, representing 
10, 20, 50 and 100% of the LD50, respectively. The 
extract was administered orally, daily for 28 days. The 
body weights of the animals were evaluated a day 
before the start of administration and then weekly for 
four weeks. 
 
Collection of Blood Samples: On the 29th day, the 
animals were sacrificed after overnight fast and the 
blood samples were collected into labeled centrifuge 
tubes and allowed to stand for 10 minutes before being 
subjected to centrifugation at 4000rpm for 15 min. The 
serum was separated from the whole blood using 
Pasteur pipette and transferred to labeled dry clean 
serum tubes and then kept refrigerated. 
 
Liver Function Tests: Total Protein was determined by 
Biuret Method (Hiller, 1926), based on reaction of 
Cupric ions in an alkaline medium, which interacts 
with protein peptide bonds resulting in the formation 
of a blue-violet complex (the so-called biuret 
reaction). Albumin was determined by Bromocresol 
Green method, measured based on its quantitative 
binding to the indicator 3,3,5,5-tetrabromo-m cresol 
sulphonephthalein (bromocresol green, BCG). 
Aspartate Aminotransferase (AST) was determined by 
monitoring the concentration of oxaloacetate 
hydrazone formed from 2,4-dinitrophenylhydrazine 
(Reitman and Frankel, 1957). Alanine 
Aminotransferase (ALT) was determined by 
monitoring the concentration of pyruvate hydrazone 
formed with 2,4-dinitrophenylhydrazine (Reitman and 
Frankel, 1957). Alkaline Phosphatase (ALP) was 
measured based on ρ-nitrophenyl phosphate, which is 
hydrolyzed to ρ- nitrophenol and inorganic phosphate 
by alkaline phosphatase at pH 10.4 (Kind and King, 
1954).  
 
Statistical Analysis: The results were analyzed using 
Analysis of Variance (ANOVA) with INstat3 software 
(SanDiago, USA). Values were expressed as mean ± 
standard deviation (SD). Differences in mean (±SD) 
were considered significant at p˂0.05. 
 
RESULTS AND DISCUSSION 
The results of the studies were presented in tables 1-3.  
All the rats survived after 48 hours of administration 
of 3000mg/kg body weight of the extract (Table 1). 
The result revealed no observable gross negative 
effects such as salivation, diarrhea, coma or 
convulsion in the rats administered the various doses 
of the extract. There were no changes on the skin 
colour or eyes, hair removal was not noticed either. All 
the rats had normal tail (flexible), granular excrement 
and would isolate themselves at the corners of the cage 
after dosing. There was no observable depressive 
effect on the central nervous system and mortality was 
not recorded. It could be concluded, therefore, that the 
LD50 for the extract is greater than 3000 mg/kg body 
weight.  
 
There was a significant (p<0.05) decrease in the body 
weight of all the groups treated with the extract when 
compared with their initial weights before treatment. 
The rats in the control group gained weight when 
compared with their initial weights (Table 2). This 
suggests that the extract had adversely affected the 
weights of the treated rats. 
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There was a significant (P<0.05) increase in ALAT in 
the rats administered 3000 mg/kg bw and 1500 mg/kg 
bw when compared with the control (Table 3). 
However, a significant (p<0.05) decrease in ALAT 
was observed in the rats administered 600 mg/kg bw 
and 300 mg/kg bw of the extract, suggesting that there 
was no adverse effect on the liver at these 
concentrations. The dose-dependent elevations 
observed in the serum enzymes in the groups 
administered 3000 mg/kg bw and 1500 mg/kg bw 
indicates possible hapatocellular damage (Sigma 
Diagnostic, 1985). There were significant (P<0.05) 
increases in ASAT and ALP when compared with the 
control in all the treated groups (Table 3). Increase in 
the activity of these enzymes in the plasma is often 
seen following liver damage and it is attributable to the 
loss of the enzyme from damaged hepatocytes rather 
than increased production (Tilkian, 1979). This also 
suggests that other non-specific tissue damage could 
have occurred as these enzymes have a wider tissue 
distribution beyond the liver (Boyd, 1988). ALAT and 
ASAT are liver specific enzyme markers of necrotic 
injury and cholestasis (Lott and Wolt, 1986). Total 
bilirubin significantly (p<0.05) increased in animals 
administered 3000 mg/kg bw and 1500 mg/kg bw 
respectively, but significantly (p<0.05) decreased in 
animals administered 600 mg/kg bw and 300 mg/kg 
bw of the extract (Table 3). The significant increase in 
total bilirubin in animals administered 3000 mg/kg bw 
and 1500 mg/kg bw suggests that the extract had 
adversely affected the excretory function of the liver. 
However, the decrease in bilirubin levels in animals 
administered 600 mg/kg bw and 300 mg/kg bw of the 
extract may be attributed to the depressant effect of the 
extract (Odutola, 1992).  
 
Albumin significantly (P<0.05) decreased in all the 
treated groups when compared with the control (Table 
3). Significant decrease in albumin in all the treated 
groups suggests that both the excretory and synthetic 
functions of the liver were altered as these are markers 
of liver excretory and synthetic functions (Weiss et al., 
1983). 
 
Table 1: The effect of administration of acute dose (3000 mg/kg bw) of aqueous leaves extract of Cassia italica on the behavior of the 
albino rats. 
Animals 0 -5min 6 – 30min 31- 59min 1 – 48 hrs 
Rat -1  Restlessness Mouth  scratch Calm Normal 
Rat -2 Restlessness Mouth  scratch Weak Normal 
Rat -3  Restlessness Mouth  scratch Weak Normal 
Rat -4  Restlessness Mouth  scratch Weak Normal 
Rat -5  Restlessness Mouth  scratch Sleep Normal 
LD50 > 3000 mg/kg body weight. 
  
Table 2:  The effect of four weeks administration of gradedt doses of aqueous leaves extract of Cassia italica on total weight of albino rats. 
 Dose (mg/kg) Initial weight Week1 Week2 Week3 week4 
0 (control) 135.4 ± 19.45 137.2 ± 19.40 139.4 ± 22.35 139.2 ± 22.60 155.2 ± 23.83 
3000 153.2 ± 2.39 152. 0 ± 15.52 153.4 ± 16.33 148.6 ± 15.37 135.4 ± 13.83 
1500 179.2 ± 3.42 171. 2 ± 7.92 169.4± 5.94 165.2 ± 06.98 165.4 ± 7.23 
600 143.6 ± 4.04 127.4 ± 15.85 127.6 ± 17.85 124.0 ± 20.58 112.0 ± 23.96 
300 163.0 ± 1.58 153.4 ± 2.88 156.8 ± 6.58 154.6 ± 6.77 157 ± 8.27 
Values were expressed as mean ± standard deviation (n=5). 
 
Table 3. The effect of administration of graded doses of aqueous leaves extract of C. italica on liver function indices of albino rats. 
Dose (mg/kg) ALAT (U/I) ASAT (U/I) ALP (U/I) Albumin (g/dl) Total bilirubin (mg/dl) 
0 (control) 50.22 ± 2.83 119.61 ± 1.42     138.64 ± 2.71 3.46 ± 0.31 1.04 ± 0.07 
3000  72.92 ± 2.32* 201.80 ± 2.67* 197.5 ± 1.00* 4.29 ± 0.54 1.37 ± 0.32* 
1500  59.12 ± 1.14* 185.95 ± 5.12*  178.13 ± 2.41* 3.39 ± 0.43 1.02 ± 0.05* 
600 52.82 ± 3.32 168.12 ± 1.18* 152.18 ± 2.56* 2.64 ± 0.38 0.73 ± 0.04 
300 44.52 ± 4.16 153.73 ± 3.54* 133.77 ± 1.68* 2.03 ± 0.43 0.67 ± 0.08 
Values expressed as mean ± standard deviation (n=5). *= Significantly different from control (P<0.05). ALAT= Alanine Aminotransferase. 
ASAT= Aspartate Aminotransferase. ALP= Alkaline Phosphatase. 
 
Conclusion: In the light of the foregoing, it is evident 
that the aqueous leaves extract of C. italica had 
adverse effects on the liver function in the treated rats, 
which were however, dose dependent. The liver 
function was impaired at higher doses while at 
therapeutic dose the leaves extracts of C. italica could 
be used to manage constipation, oedema and skin 
infections with an acceptable margin of safety.  
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